Bristozole 2.5mg Tab
Letrozole 2.5mg tablets for breast cancer.
Bristozole 2.5mg Tab contain letrozole 2.5mg (aromatase inhibitor) for hormone-receptor-positive breast cancer in postmenopausal women. Take as directed; usually once daily. Do not stop without medical advice.
Purpose
Treatment of hormone-receptor-positive breast cancer in postmenopausal women when prescribed.
Ingredients
Letrozole 2.5mg per tablet.
Warnings
Prescription only. Not for use in premenopausal women or pregnancy. Report joint pain or bone symptoms. Long-term use may reduce bone density; follow monitoring advice.
Side Effects
Hot flushes, joint pain, fatigue. Osteoporosis risk; bone density monitored. Report unexplained bone pain or fractures.
Storage Instructions
Store below 25°C in a dry place. Keep in original pack; protect from moisture. Keep out of reach of children.
| Brand | Bristol |
| Status | Active |
Related Products
